Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $737.52 ($74K) on 2023-06-01, disclosed to the SEC on 2023-06-02.
Scheduled sale ($74k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $730.03 | 2 | $1K | 2.0% |
| 2 | $731.49 | 9 | $7K | 9.0% |
| 3 | $732.49 | 10 | $7K | 10.0% |
| 4 | $733.61 | 2 | $1K | 2.0% |
| 5 | $734.62 | 10 | $7K | 10.0% |
| 6 | $735.42 | 12 |
| $9K |
| 12.0% |
| 7 | $736.40 | 31 | $23K | 31.0% |
| 8 | $737.52 | 17 | $13K | 17.0% |
| 9 | $738.35 | 7 | $5K | 7.0% |
| Total | $735.42 avg | 100 | $74K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |